Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inappropriate Laboratory Testing Found Throughout Medicine

By LabMedica International staff writers
Posted on 02 Dec 2013
Laboratory testing is the single highest-volume medical activity and drives clinical decision-making across medicine with over five billion tests performed each year in the USA.

The overall landscape of inappropriate testing, which is thought to be dominated by repeat testing, is unclear. More...
Systematic differences in initial versus repeat testing, measurement criteria, and other factors would suggest new priorities for improving laboratory testing.

Scientists at the Harvard Medical School (Boston, MA, USA) and colleagues from Beth Israel Deaconess Medical Center (BIDMC; Boston MA, USA) performed a multi-database systematic review on published studies from 1997–2012. For measures of overutilization, they determined whether the inappropriateness criteria were objective or subjective; restrictive, permissive, or both; and whether they involved initial testing, repeat testing, or both. Test volume, low, medium, or high was also determined.

From these measurements, they set about estimating the overall prevalence of inappropriate testing, including overuse, tests that are ordered but not indicated, and underuse tests that are indicated but not ordered. They also distinguished between inappropriate initial testing, during a clinician's first evaluation of a patient or in response to new signs or symptoms, and inappropriate repeat testing, which occurs when the same tests are repeated, often multiple times, during a patient's hospitalization.

The authors found that not only was there a 30% overall rate of test overuse, there was a similar rate of underuse. On average, the available evidence suggests that underutilization is more prevalent than overutilization, 44.8% versus 20.6%. Ramy Arnaout, MD, DPhil, the senior author, said, “It's not ordering more tests or fewer tests that we should be aiming for, it's ordering the right tests, however few or many that is. Remember, laboratory tests are inexpensive. Ordering one more test or one less test isn't going to ‘bend the curve,’ even if we do it across the board. It's everything that happens next: the downstream visits, the surgeries, the hospital stays that matters to patients and to the economy and should matter to us.”

William Taylor, MD, a clinician in BIDMC's Division of General Medicine and Primary Care, said, “Because laboratory tests play such a crucial and ubiquitous role in medicine, efforts to identify opportunities for improvement in the selection of tests have the potential to contribute greatly to the care patients receive. By drawing attention to this important topic, the authors are setting the stage for further work to help more patients benefit from proper test selection, while protecting patients from the potential harm and wasted resources induced by unnecessary tests.” The study was published on November 15, 2013, in the journal Public Library of Science ONE.

Related Links:

Harvard Medical School
Beth Israel Deaconess Medical Center 



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.